LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

CUSIP: 528872302

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-7,948
SEC-reported price per share
$1.88
Number of holders
15
Value change
-$14,859
Number of buys
3
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
442,581,578

Security key

528872302

Report period

Q3 2026

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
Artal Group S.A.
Comparable rows
2/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 39% 13 rows are not safely comparable across share classes. 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 39%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership Top 2
Invus Global Management, LLC 39%
FMR LLC 12%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus Global Management, LLC
13D/G 3/4/5
Artal Participations S.a r.l. · Director, 10%+ Owner
39%
Reported 13D/G · 30 Apr 2026
$273,243,457
175,156,062 shares
+$31,857,907 30 Apr 2026
FMR LLC
13D/G 13F
Company
12%
Reported 13D/G · 30 Jun 2026
$124,276,907
51,782,045 shares
+$32,746,824 30 Jun 2026
Artal Group S.A.
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$420,374,549
175,156,062 shares
— 30 Jun 2026
Artal Participations S.a r.l.
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$299,791,711
175,156,062 shares
mixed-class rows
— 30 Apr 2026
Administratiekantoor Westend Stichting
3/4/5
Director, 10%+ Owner
—
denominator unverified
$273,243,456
175,156,062 shares
— 30 Apr 2026
Amaury Wittouck
3/4/5
Director, 10%+ Owner
—
denominator unverified
$273,243,456
175,156,062 shares
— 30 Apr 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
380,450
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
148
Q3 2026 holders
15
Holder diff
-133
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .